Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
Public ClinicalTrials.gov record NCT03219320. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Assess the Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the efficacy of multiple dose levels of NYX-2925 versus placebo in treating the neuropathic pain associated with Diabetic Peripheral Neuropathy.
Study identification
- NCT ID
- NCT03219320
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 301 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 26, 2017
- Primary completion
- Nov 1, 2018
- Completion
- Nov 1, 2018
- Last update posted
- Jun 8, 2020
2017 – 2018
United States locations
- U.S. sites
- 35
- U.S. states
- 14
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Aptinyx Clinical Site | Phoenix | Arizona | 85053 | — |
| Aptinyx Clinical Site | Anaheim | California | 92801 | — |
| Aptinyx Clinical Site | Fresno | California | 93710 | — |
| Aptinyx Clinical Site | Norco | California | 92860 | — |
| Aptinyx Clinical Site | Santa Monica | California | 90404 | — |
| Aptinyx Clinical Site | Tustin | California | 92480 | — |
| Aptinyx Clinical Site | New London | Connecticut | 06320 | — |
| Aptinyx Clinical Site | Bradenton | Florida | 34201 | — |
| Aptinyx Clinical Site | Brandon | Florida | 33511 | — |
| Aptinyx Clinical Site | Fort Myers | Florida | 33912 | — |
| Aptinyx Clinical Site | Hallandale | Florida | 33009 | — |
| Aptinyx Clinical Site | Jupiter | Florida | 33458 | — |
| Aptinyx Clinical Site | Miami | Florida | 33012 | — |
| Aptinyx Clinical Site | Miami | Florida | 33126 | — |
| Aptinyx Clinical Site | Miami | Florida | 33175 | — |
| Aptinyx Clinical Site | Ocoee | Florida | 34761 | — |
| Aptinyx Clinical Site | Orlando | Florida | 32801 | — |
| Aptinyx Clinical Site | Orlando | Florida | 32806 | — |
| Aptinyx Clinical Site | Tampa | Florida | 33603 | — |
| Aptinyx Clinical Site | West Palm Beach | Florida | 33401 | — |
| Aptinyx Clinical Site | Columbus | Georgia | 31904 | — |
| Aptinyx Clinical Site | Decatur | Georgia | 30033 | — |
| Aptinyx Clinical Site | Meridian | Idaho | 83642 | — |
| Aptinyx Clinical Site | Flossmoor | Illinois | 60422 | — |
| Aptinyx Clinical Site | Hazelwood | Missouri | 63042 | — |
| Aptinyx Clinical Site | Berlin | New Jersey | 08009 | — |
| Aptinyx Clinical Site | Rochester | New York | 14618 | — |
| Aptinyx Clinical Site | Dayton | Ohio | 45439 | — |
| Aptinyx Clinical Site | Knoxville | Tennessee | 37909 | — |
| Aptinyx Clinical Site | Memphis | Tennessee | 38119 | — |
| Aptinyx Clinical Site | Tullahoma | Tennessee | 37388 | — |
| Aptinyx Clinical Site | Austin | Texas | 78731 | — |
| Aptinyx Clinical Site | Houston | Texas | 77058 | — |
| Aptinyx Clinical Site | Plano | Texas | 75024 | — |
| Aptinyx Clinical Site | Norfolk | Virginia | 23510 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03219320, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 8, 2020 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03219320 live on ClinicalTrials.gov.